by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Vivera Pharmaceuticals, Inc. Warning Letter Details

Warning Letter

Vivera Pharmaceuticals, Inc.

Vivera Pharmaceuticals, Inc., 26021 Pala Drive - St A Mission Viejo , CA 92691 United States

Issue DateJuly 26, 2021

FEI NumberN/A

Violations1

CountryUnited States

Issuing Office

Center for Devices and Radiological Health

Product Type

Medical Devices

Status

Open

Subject

Adulterated and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

Vivera Pharmaceuticals, Inc. FDA Warning Letter, July 26, 2021